Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 4
1956 2
1957 4
1958 4
1959 3
1960 3
1962 3
1974 1
1977 3
1978 13
1979 21
1980 17
1981 33
1982 38
1983 47
1984 52
1985 50
1986 78
1987 93
1988 138
1989 163
1990 141
1991 147
1992 153
1993 132
1994 179
1995 201
1996 222
1997 296
1998 210
1999 282
2000 266
2001 282
2002 286
2003 296
2004 316
2005 356
2006 389
2007 411
2008 434
2009 492
2010 562
2011 623
2012 652
2013 824
2014 761
2015 867
2016 898
2017 869
2018 998
2019 963
2020 676
2021 432
2022 973
2023 882
2024 301

Text availability

Article attribute

Article type

Publication date

Search Results

15,189 results

Results by year

Filters applied: . Clear all
Page 1
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, Collins EC, Solomon P, Salloway S, Apostolova LG, Hansson O, Ritchie C, Brooks DA, Mintun M, Skovronsky DM; TRAILBLAZER-ALZ 2 Investigators. Sims JR, et al. JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239. JAMA. 2023. PMID: 37459141 Free PMC article.
A New Framework for Dementia Nomenclature.
Petersen RC, Weintraub S, Sabbagh M, Karlawish J, Adler CH, Dilworth-Anderson P, Frank L, Huling Hummel C, Taylor A; Dementia Nomenclature Initiative. Petersen RC, et al. JAMA Neurol. 2023 Dec 1;80(12):1364-1370. doi: 10.1001/jamaneurol.2023.3664. JAMA Neurol. 2023. PMID: 37843871 Review.
Trial of Solanezumab in Preclinical Alzheimer's Disease.
Sperling RA, Donohue MC, Raman R, Rafii MS, Johnson K, Masters CL, van Dyck CH, Iwatsubo T, Marshall GA, Yaari R, Mancini M, Holdridge KC, Case M, Sims JR, Aisen PS; A4 Study Team. Sperling RA, et al. N Engl J Med. 2023 Sep 21;389(12):1096-1107. doi: 10.1056/NEJMoa2305032. Epub 2023 Jul 17. N Engl J Med. 2023. PMID: 37458272 Free PMC article. Clinical Trial.
Lecanemab Questions.
Nadeau SE. Nadeau SE. Neurology. 2024 Apr 9;102(7):e209320. doi: 10.1212/WNL.0000000000209320. Epub 2024 Mar 14. Neurology. 2024. PMID: 38484213
Umbrella review and Delphi study on modifiable factors for dementia risk reduction.
Rosenau C, Köhler S, Soons LM, Anstey KJ, Brayne C, Brodaty H, Engedal K, Farina FR, Ganguli M, Livingston G, Lyketsos CG, Mangialasche F, Middleton LE, Rikkert MGMO, Peters R, Sachdev PS, Scarmeas N, Salbaek G, van Boxtel MPJ, Deckers K. Rosenau C, et al. Alzheimers Dement. 2024 Mar;20(3):2223-2239. doi: 10.1002/alz.13577. Epub 2023 Dec 30. Alzheimers Dement. 2024. PMID: 38159267 Free PMC article. Review.
15,189 results
You have reached the last available page of results. Please see the User Guide for more information.